BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 20198494)

  • 1. Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors.
    Roosenburg S; Laverman P; van Delft FL; Boerman OC
    Amino Acids; 2011 Nov; 41(5):1049-58. PubMed ID: 20198494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors.
    Behr TM; Jenner N; Béhé M; Angerstein C; Gratz S; Raue F; Becker W
    J Nucl Med; 1999 Jun; 40(6):1029-44. PubMed ID: 10452322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies.
    Behr TM; Béhé MP
    Semin Nucl Med; 2002 Apr; 32(2):97-109. PubMed ID: 11965605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeled gastrin/CCK analogs in tumor diagnosis: towards higher stability and improved tumor targeting.
    Kaloudi A; Nock BA; Krenning EP; Maina T; De Jong M
    Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):287-302. PubMed ID: 26158215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
    Behr TM; Béhé M; Angerstein C; Gratz S; Mach R; Hagemann L; Jenner N; Stiehler M; Frank-Raue K; Raue F; Becker W
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of CCK-2 receptor-expressing tumors using a radiolabeled divalent gastrin peptide.
    Sosabowski JK; Matzow T; Foster JM; Finucane C; Ellison D; Watson SA; Mather SJ
    J Nucl Med; 2009 Dec; 50(12):2082-9. PubMed ID: 19910426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence for a C-terminal structural motif in CCK2 receptor active peptide hormones.
    Stone SR; Giragossian C; Mierke DF; Jackson GE
    Peptides; 2007 Nov; 28(11):2211-22. PubMed ID: 17950490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation.
    Roosenburg S; Laverman P; Joosten L; Eek A; Oyen WJ; de Jong M; Rutjes FP; van Delft FL; Boerman OC
    Bioconjug Chem; 2010 Apr; 21(4):663-70. PubMed ID: 20302291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biology of cholecystokinin and gastrin peptides.
    Rehfeld JF; Friis-Hansen L; Goetze JP; Hansen TV
    Curr Top Med Chem; 2007; 7(12):1154-65. PubMed ID: 17584137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrin and cholecystokinin peptide-based radiopharmaceuticals: an in vivo and in vitro comparison.
    Tornesello AL; Aurilio M; Accardo A; Tarallo L; Barbieri A; Arra C; Tesauro D; Morelli G; Aloj L
    J Pept Sci; 2011 May; 17(5):405-12. PubMed ID: 21351319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors.
    Laverman P; Béhé M; Oyen WJ; Willems PH; Corstens FH; Behr TM; Boerman OC
    Bioconjug Chem; 2004; 15(3):561-8. PubMed ID: 15149184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma.
    Fröberg AC; de Jong M; Nock BA; Breeman WA; Erion JL; Maina T; Verdijsseldonck M; de Herder WW; van der Lugt A; Kooij PP; Krenning EP
    Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1265-72. PubMed ID: 19266197
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.